Page 1 | Search Results | Cancer Research | American Association for Cancer Research

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Abstract 7584: The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma

Abbas Jawadwala, Christopher Rupert, Remi Adelaiye-Ogala, Roberto Pili, Sreenivasulu Chintala, Ashley Orillion, May Elbanna, Nur Damayanti, Ilaria Delle Fontane

Cancer Res (2024) 84 (6_Supplement): 7584.

https://doi.org/10.1158/1538-7445.AM2024-7584

Published: 22 March 2024

View articletitled, Abstract 7584: The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma

Journal Articles

Abstract 4239: Alternate-day fasting enhances the activity of anti-androgen therapy in prostate cancer models

Ricardo Cordova, May Elbanna, Angela Klunk, Christopher Rupert, Li Shen, Yanqing Wang, David Goodrich, Ron Wek, Kirk Staschke, Luigi Fontana, Roberto Pili

Cancer Res (2023) 83 (7_Supplement): 4239.

https://doi.org/10.1158/1538-7445.AM2023-4239

Published: 04 April 2023

View articletitled, Abstract 4239: Alternate-day fasting enhances the activity of anti-androgen therapy in prostate cancer models

Journal Articles

Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer

May Elbanna, Justin Budka, Paige Dausinas, Remi Adelaiye-Ogala, Nur Damayanti, Ashley Orillion, Eri Banno, Luigi Fontana, Roberto Pili

Cancer Res (2019) 79 (13_Supplement): 1611.

https://doi.org/10.1158/1538-7445.AM2019-1611

Published: 01 July 2019

View articletitled, Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer

Journal Articles

Abstract 3109: Investigating the role of wild-type TFE3 in renal cell carcinoma cells harboring TFE3 fusions with spliceosome machinery associated genes

Nur P. Damayanti, Khunsha Ahmed, May Elbanna, Chinghai Kao, Roberto Pili

Cancer Res (2018) 78 (13_Supplement): 3109.

https://doi.org/10.1158/1538-7445.AM2018-3109

Published: 01 July 2018

View articletitled, Abstract 3109: Investigating the role of wild-type TFE3 in renal cell carcinoma cells harboring TFE3 fusions with spliceosome machinery associated genes

Journal Articles

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Cancer Res (2017) 77 (23): 6651–6666.

https://doi.org/10.1158/0008-5472.CAN-17-0899

Published: 30 November 2017

View articletitled, EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Includes: Supplementary data

Journal Articles

Abstract 250: Methionine restriction increases macrophage tumoricidal activity and significantly inhibits prostate cancer growth

Ashley R. Orillion, Sreenivasulu Chintala, Remi Adelaiye-Ogala, Li Shen, Nur Damayanti, May Elbanna, Sreevani Arisa, Bennett Elzey, Chinghai Kao, Luigi Fontana, Roberto Pili

Cancer Res (2017) 77 (13_Supplement): 250.

https://doi.org/10.1158/1538-7445.AM2017-250

Published: 01 July 2017

View articletitled, Abstract 250: Methionine restriction increases macrophage tumoricidal activity and significantly inhibits prostate cancer growth

Journal Articles

Abstract 5783: In vitro modeling of patient derived bladder cancer cell lines in 3D culture systems

May Elbanna, Sreenivasulu Chintala, Eric Ciamporcero, Remi Adelayie, Ashley Orillion, Sreevani Arisa, Nur Damayanti, Michelle Grimard, TJ Puls, Sherry Harbin, Melissa Fishel, Roberto Pili

Cancer Res (2017) 77 (13_Supplement): 5783.

https://doi.org/10.1158/1538-7445.AM2017-5783

Published: 01 July 2017

View articletitled, Abstract 5783: In vitro modeling of patient derived bladder cancer cell lines in 3D culture systems

Journal Articles

Abstract 4170: Targeting androgen receptor overcomes resistance to tyrosine kinase inhibitors in advanced clear cell renal cell carcinoma

Remi M. Adelaiye-Ogala, Sreenivasulu Chintala, Ashley Orillion, May Elbanna, Ben Elzey, Nur Damayanti, Kiersten M. Miles, Chinghai Kao, Piergiorgio Pettazzoni, Giulio F. Draetta, Roberto Pili

Cancer Res (2017) 77 (13_Supplement): 4170.

https://doi.org/10.1158/1538-7445.AM2017-4170

Published: 01 July 2017

View articletitled, Abstract 4170: Targeting androgen receptor overcomes resistance to tyrosine kinase inhibitors in advanced clear cell renal cell carcinoma

Journal Articles

Abstract 94: Association of xCT overexpression with RTKI resistance and metastases in clear cell renal cell carcinoma

Sreenivasulu Chintala, Remi Adelaiye-Ogala, Ashley Orillion, Sreevani Arisa, May Elbanna, Nur P. Damayanti, Roberto Pili

Cancer Res (2017) 77 (13_Supplement): 94.

https://doi.org/10.1158/1538-7445.AM2017-94

Published: 01 July 2017

View articletitled, Abstract 94: Association of xCT overexpression with RTKI resistance and metastases in clear cell renal cell carcinoma

Journal Articles

Abstract 897: Methionine restriction alters functional polarization of macrophages in a murine model of prostate cancer

Ashley Orillion, Remi Adelaiye-Ogala, Li Shen, Eric Ciamporcero, May Elbanna, Sreenivasulu Chintala, Sreevani Arisa, Ben Elzey, Chinghai Kao, Luigi Fontana, Roberto Pili

Cancer Res (2016) 76 (14_Supplement): 897.

https://doi.org/10.1158/1538-7445.AM2016-897

Published: 15 July 2016

View articletitled, Abstract 897: Methionine restriction alters functional polarization of macrophages in a murine model of prostate cancer

Journal Articles

Abstract 955: Inhibition of SEC24D decreases exosome release of the tumor suppressor miR-605 in renal cell carcinoma

Sreenivasulu Chintala, Remi Adelaiye-Ogala, Ashley Orillion, Sreevani Arisa, May Elbanna, Roberto Pili

Cancer Res (2016) 76 (14_Supplement): 955.

https://doi.org/10.1158/1538-7445.AM2016-955

Published: 15 July 2016

View articletitled, Abstract 955: Inhibition of SEC24D decreases exosome release of the tumor suppressor miR-605 in renal cell carcinoma

Journal Articles

Abstract 2126: Androgen receptor expression is associated with sunitinib resistance in renal cell carcinoma models

Remi M. Adelaiye-Ogala, Sreenivasulu Chintala, Ashley Orillion, Piergiorgio Pettazzoni, May Elbanna, Bennett Elzey, Kiersten Marie Miles, Chinghai Kao, Giulio F. Draetta, Roberto Pili

Cancer Res (2016) 76 (14_Supplement): 2126.

https://doi.org/10.1158/1538-7445.AM2016-2126

Published: 15 July 2016

View articletitled, Abstract 2126: Androgen receptor expression is associated with sunitinib resistance in renal cell carcinoma models

Journal Articles

Abstract 4906: The selective class I HDAC inhibitor entinostat enhances the antitumor effect of PD-1 inhibition in a syngeneic orthotopic murine model of renal cell carcinoma

Ashley R. Orillion, Li Shen, Remi Adelaiye-Ogala, May Elbanna, Sreenivasulu Chintala, Sreevani Arisa, Roberto Pili

Cancer Res (2016) 76 (14_Supplement): 4906.

https://doi.org/10.1158/1538-7445.AM2016-4906

Published: 15 July 2016

View articletitled, Abstract 4906: The selective class I HDAC inhibitor entinostat enhances the antitumor effect of PD-1 inhibition in a syngeneic orthotopic murine model of renal cell carcinoma

Journal Articles

Abstract 3508: Inhibition of EZH2 overcomes resistance to sunitinib in clear cell renal cell carcinoma models

Remi M. Adelaiye-Ogala, Sreenivasulu Chintala, Li Shen, Ashley Orillion, Eric Ciamporcero, May Elbanna, Kiersten Marie Miles, Bryan Gillard, Michael Buck, Roberto Pili

Cancer Res (2015) 75 (15_Supplement): 3508.

https://doi.org/10.1158/1538-7445.AM2015-3508

Published: 01 August 2015

View articletitled, Abstract 3508: Inhibition of EZH2 overcomes resistance to sunitinib in clear cell renal cell carcinoma models

Journal Articles

Abstract 4110: Inhibition of angiopoietin 1/2 and c-MET impairs metastatic potential in a patient derived xenograft of renal carcinoma

Ashley Orillion, Remi Adelaiye-Ogala, Li Shen, Eric Ciamporcero, Sheng Yu Ku, Swathi Ramakrishnan, May Elbanna, Sreenivasulu Chintala, Roberto Pili

Cancer Res (2015) 75 (15_Supplement): 4110.

https://doi.org/10.1158/1538-7445.AM2015-4110

Published: 01 August 2015

View articletitled, Abstract 4110: Inhibition of angiopoietin 1/2 and c-MET impairs metastatic potential in a patient derived xenograft of renal carcinoma

Journal Articles

Abstract 4132: Anti-tumor and anti-metastatic effect of sunitinib in a patient derived metastatic clear cell renal cell carcinoma xenograft model

Remi M. Adelaiye-Ogala, Li Shen, Sreenivasulu Chintala, Eric Ciamporcero, Ashley Orillion, May Elbanna, Shengyu Ku, Kiersten Marie Miles, Bryan Gillard, Michael Buck, Roberto Pili

Cancer Res (2015) 75 (15_Supplement): 4132.

https://doi.org/10.1158/1538-7445.AM2015-4132

Published: 01 August 2015

View articletitled, Abstract 4132: Anti-tumor and anti-metastatic effect of sunitinib in a patient derived metastatic clear cell renal cell carcinoma xenograft model

Journal Articles

Abstract 4300: Solute carrier family group of membrane transporter gene alteration in collecting duct renal cell carcinoma

Sreenivasulu Chintala, Jianmin Wang, Lei Wei, Biao Liu, Eric Ciamporcero, Kiersten Marie Miles, May Elbanna, Remi Adelaiye, Li Shen, Ashley Orillion, Sheng Yu Ku, Antonios Papanicolau-Sengos, Carl D. Morrison, Roberto Pili

Cancer Res (2015) 75 (15_Supplement): 4300.

https://doi.org/10.1158/1538-7445.AM2015-4300

Published: 01 August 2015

View articletitled, Abstract 4300: Solute carrier family group of membrane transporter gene alteration in collecting duct renal cell carcinoma

Journal Articles

Abstract 1013: Angiopoietin 1/2 inhibition impairs tumor growth in an orthotopic model of renal cell carcinoma

Ashley Orillion, Kiersten Marie Miles, Li Shen, Remi Adelaiye, Eric Ciamporcero, Swathi Ramakrishnan, Sheng Yu Ku, May Elbanna, Sreenivasulu Chintala, Roberto Pili

Cancer Res (2014) 74 (19_Supplement): 1013.

https://doi.org/10.1158/1538-7445.AM2014-1013

Published: 01 October 2014

View articletitled, Abstract 1013: Angiopoietin 1/2 inhibition impairs tumor growth in an orthotopic model of renal cell carcinoma

Journal Articles

Abstract 1375: Epigenetic changes associated with resistance to sunitinib in human clear cell renal cell carcinoma models

REMI ADELAIYE, Kiersten Marie Miles, Eric Ciamporcero, Dylan Conroy, Swathi Ramakrishnan, Ashley Orillion, Sheng Y. Ku, May Elbanna, Li shen, Sreenivasulu Chintala, Roberto Pili

Cancer Res (2014) 74 (19_Supplement): 1375.

https://doi.org/10.1158/1538-7445.AM2014-1375

Published: 01 October 2014

View articletitled, Abstract 1375: Epigenetic changes associated with resistance to sunitinib in human clear cell renal cell carcinoma models

Update search

NARROW

Format

Subjects

Journal

Article Type

Issue Section

Date

Availability

Abstract 7584: The solute transported xCT (SLC7A11) modulates lysosome biogenesis and microRNA trafficking in drug resistant renal cell carcinoma

Abstract 4239: Alternate-day fasting enhances the activity of anti-androgen therapy in prostate cancer models

Abstract 1611: Caloric restriction potentiates the therapeutic benefit of androgen deprivation therapy and alters macrophage polarization when combined with PD1 inhibition in murine models of prostate cancer

Abstract 3109: Investigating the role of wild-type TFE3 in renal cell carcinoma cells harboring TFE3 fusions with spliceosome machinery associated genes

EZH2 Modifies Sunitinib Resistance in Renal Cell Carcinoma by Kinome Reprogramming

Abstract 250: Methionine restriction increases macrophage tumoricidal activity and significantly inhibits prostate cancer growth

Abstract 5783: In vitro modeling of patient derived bladder cancer cell lines in 3D culture systems

Abstract 4170: Targeting androgen receptor overcomes resistance to tyrosine kinase inhibitors in advanced clear cell renal cell carcinoma

Abstract 94: Association of xCT overexpression with RTKI resistance and metastases in clear cell renal cell carcinoma

Abstract 897: Methionine restriction alters functional polarization of macrophages in a murine model of prostate cancer

Abstract 955: Inhibition of SEC24D decreases exosome release of the tumor suppressor miR-605 in renal cell carcinoma

Abstract 2126: Androgen receptor expression is associated with sunitinib resistance in renal cell carcinoma models

Abstract 4906: The selective class I HDAC inhibitor entinostat enhances the antitumor effect of PD-1 inhibition in a syngeneic orthotopic murine model of renal cell carcinoma

Abstract 3508: Inhibition of EZH2 overcomes resistance to sunitinib in clear cell renal cell carcinoma models

Abstract 4110: Inhibition of angiopoietin 1/2 and c-MET impairs metastatic potential in a patient derived xenograft of renal carcinoma

Abstract 4132: Anti-tumor and anti-metastatic effect of sunitinib in a patient derived metastatic clear cell renal cell carcinoma xenograft model

Abstract 4300: Solute carrier family group of membrane transporter gene alteration in collecting duct renal cell carcinoma

Abstract 1013: Angiopoietin 1/2 inhibition impairs tumor growth in an orthotopic model of renal cell carcinoma

Abstract 1375: Epigenetic changes associated with resistance to sunitinib in human clear cell renal cell carcinoma models

Email alerts

AACR Journals

Update search

Email alerts

AACR Journals

This Feature Is Available To Subscribers Only